Estimating the Benefits of the Proposed FDA Sodium Reformulation Policy on Cardiovascular Disease, Disparities and Economic Costs



Pearson-Stuttard, Jonathan, Kypridemos, Chris ORCID: 0000-0002-0746-9229, Collins, Brendan ORCID: 0000-0002-3023-8189, Huang, Yue, Bandosz, Piotr, Whitsel, Laurie, Capewell, Simon ORCID: 0000-0003-3960-8999, Mozaffarian, Dariush, Wilde, Parke, O'Flaherty, Martin ORCID: 0000-0001-8944-4131
et al (show 1 more authors) (2018) Estimating the Benefits of the Proposed FDA Sodium Reformulation Policy on Cardiovascular Disease, Disparities and Economic Costs In: American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2018 Scientific Sessions, 2018-3-20 - 2018-3-23, New Orleans, Louisiana.

[thumbnail of Estimating the Benefits of the Proposed FDA Sodium Reformulation Policy on Cardiovascular Disease.docx] Text
Estimating the Benefits of the Proposed FDA Sodium Reformulation Policy on Cardiovascular Disease.docx - Author Accepted Manuscript

Download (25kB)
Item Type: Conference Item (Unspecified)
Uncontrolled Keywords: Diet, Sodium, Disparities
Depositing User: Symplectic Admin
Date Deposited: 22 Mar 2018 14:46
Last Modified: 16 Jun 2026 13:14
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3019333
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.